2017 Drug Design and Delivery Symposium

This year of the symposium was organized to highlight the work being done by chemists to combat some of the diseases that plague us. Select any of the sessions below to hear experts detail the work that is being done in oncology, anti-infectives and immunology.

I - Fighting Cancer
January 26	Fighting Cancer: Targeting CNS Malignancy with Kinase Inhibitors Timothy P. Heffron - Genentech Mark Wittman - Bristol-Myers Squibb
February 23	Fighting Cancer: Epigenetic targets for Oncology Stuart Conway - Oxford Sharan Bagal - AstraZeneca
March 23	Fighting Cancer: Allostery and Targeting Cancer Cell Metabolism Stefan Gross - Agios Scott Edmundson - AstraZeneca
Special Broadcast
April 20	Cystic Fibrosis: Discovery of CFTR Modulators Peter Grootenhuis - Vertex Nick Meanwell - Bristol-Myers Squibb
II - Anti-infectives
May 25	Anti-Infectives: Rational Approaches to the Design and Optimization Jason Sello - Brown University Courtney Aldrich - University of Minnesota
June 29	Tuberculosis: An Introduction for Medicinal Chemists Carl Nathan - Weill Cornell Medicine Christopher Boyce - Merck
July 27	Viral Hepatitis: The Search for a Cure Mike Sofia - Arbutus Biopharma Stephen Mason - CaroGen Corporation
Special Broadcast
September 28	Spinal Muscular Atrophy Kevin Hodgetts - Harvard Medical School Alyson Weidmann - ACS Publications
III - Immunology
October 26	Psoriasis: Treatment and Novel Approaches Frank Narjes - AstraZeneca John Morrison - Bristol-Myers Squibb
November 30	Treating Lupus: SLE Pathogenesis and Targeted Therapies Laurence Menard - Bristol-Myers Squibb Mary Struthers - Bristol-Myers Squibb